...
首页> 外文期刊>The biochemical journal >Biochemical and thermodynamic characterization of mutated β1,4-galactosyltransferase 7 involved in the progeroid form of the Ehlers–Danlos syndrome
【24h】

Biochemical and thermodynamic characterization of mutated β1,4-galactosyltransferase 7 involved in the progeroid form of the Ehlers–Danlos syndrome

机译:生化和热力学表征的突变的β1,4-半乳糖基转移酶7参与了Ehlers–Danlos综合征的早衰型

获取原文
           

摘要

pThree mutations of the iB4GALT7/i gene [encoding β1,4-GalT7 (β1,4-galactosyltransferase 7)], corresponding to A186D, L206P and R270C, have been identified in patients with the progeroid form of the Ehlers–Danlos syndrome and are described as being associated with the reduction or loss of β1,4-GalT7 activity. However, the molecular basis of the reduction or loss of activity remained to be determined. In the present study, wild-type, A186D, L206P and R270C β1,4-GalT7 were expressed in iCHO618/i cells as membrane proteins and in iEscherichia coli/i as soluble proteins fused to MBP (maltose-binding protein). The ability of the expressed proteins to transfer galactose from donor to acceptor substrates was systematically characterized by kinetic analysis. The physicochemical properties of soluble proteins were explored by isothermal titration calorimetry, which is a method of choice when determining the thermodynamic parameters of the binding of substrates. Together, the results showed that: (i) the L206P mutation abolished the activity when L206P β1,4GalT7 was either inserted in the membrane or expressed as a soluble MBP–full-length fusion protein; (ii) the A186D mutation weakly impaired the binding of the donor substrate; and (iii) the R270C mutation strongly impaired the binding of the acceptor substrate. Moreover, the iex vivo/i consequences of the mutations were investigated by evaluating the priming efficiency of xylosides on GAG (glycosaminoglycan) chain initiation. The results demonstrate a quantitative effect on GAG biosynthesis, depending on the mutation; GAG biosynthesis was fully inhibited by the L206P mutation and decreased by the R270C mutation, whereas the A186D mutation did not affect GAG biosynthesis severely./p
机译:>早衰型患者中已鉴定出与i186B,L206P和R270C相对应的 B4GALT7 基因的三个突变[编码β1,4-GalT7(β1,4-半乳糖基转移酶7)] Ehlers-Danlos综合征,被描述为与β1,4-GalT7活性降低或丧失有关。但是,活性降低或丧失的分子基础尚待确定。在本研究中,野生型A186D,L206P和R270Cβ1,4-GalT7在 CHO618 细胞中以膜蛋白形式表达,在大肠埃希氏菌中以与之融合的可溶性蛋白表达。 MBP(麦芽糖结合蛋白)。通过动力学分析系统地表征了表达的蛋白质将半乳糖从供体向受体底物转移的能力。通过等温滴定量热法探索了可溶性蛋白的理化性质,这是确定底物结合的热力学参数时的一种选择方法。在一起的结果表明:(i)当L206Pβ1,4GalT7插入膜中或表达为可溶性MBP全长融合蛋白时,L206P突变取消了活性; (ii)A186D突变弱削弱了供体底物的结合; (iii)R270C突变强烈损害受体底物的结合。此外,通过评估木糖苷对GAG(糖胺聚糖)链起始的启动效率,研究了突变的离体后果。结果证明了对GAG生物合成的定量影响,具体取决于突变。 L206P突变完全抑制GAG的生物合成,R270C突变完全抑制GAG的生物合成,而A186D突变并未严重影响GAG的生物合成。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号